SOURCE: Marathon Patent Group

Marathon Patent Group

May 12, 2016 08:00 ET

Erich Spangenberg Joins Marathon Patent Group Management Team

Renowned IP Industry Veteran Will Focus on European and Asian Opportunities

LOS ANGELES, CA--(Marketwired - May 12, 2016) - Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"), a patent licensing and commercialization company, announced today that it has named Erich Spangenberg its Director of Acquisitions, Licensing, and Strategy. Mr. Spangenberg will primarily focus on acquisitions, licensing, alliances and strategy for Marathon, with an emphasis on Marathon's expansion into Asia and Europe.

Doug Croxall, CEO and Chairman of Marathon stated, "Erich is well known in the IP industry and was always my top choice to advise on strategy. We have known each other for years and work well together. I have also asked Erich to join our recently formed Asset Management Committee which reviews and makes final recommendations to the Board of Directors on all patent acquisitions and other significant transactions."

Erich Spangenberg commented, "The patent market is in turmoil and under incredible pressure, so this is exactly the time I want to jump back in and join Doug and the rest of the Marathon team at what I believe is a historic point of opportunity in the patent market."

Mr. Spangenberg continued, "I plan to spend the majority of my time on the ground in Europe and Asia working primarily with large corporate patent owners on various monetization opportunities. We are also working on new and significant opportunities beyond traditional licensing that potentially offer very attractive returns. It is my belief that focused monetization efforts in Asia and Europe can contribute significantly to future top and bottom line growth at Marathon."

Spangenberg is the founder and former CEO of IP Navigation Group (IPNav). He is also the founder and former CEO of nXn Partners (predictive analytics). Mr. Spangenberg was previously a partner at the prestigious law firm, Jones Day, as well as an investment banking executive at Donaldson, Lufkin & Jenrette. He is regularly quoted and featured in major news and industry trade publications and his influence in the IP space has resulted in numerous industry recognitions.

About Marathon Patent Group

Marathon is a patent licensing and commercialization company. The Company acquires patents from a wide-range of patent holders from individual inventors to Fortune 500 companies. Marathon's strategy of acquiring patents that cover a wide-range of subject matter allows the Company to achieve diversity within its patent asset portfolio. Marathon generates revenue with its diversified portfolio through actively managed concurrent patent rights enforcement campaigns. This approach is expected to result in a long-term, diversified revenue stream. The Company's commercialization division is focused on the full commercialization lifecycle which includes discovering opportunities, performing due diligence, providing capital, managing development, protecting and developing IP, assisting in execution of the business plan, and realizing shareholder value. To learn more about Marathon Patent Group, visit www.marathonpg.com.

Safe Harbor Statement

Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contact Information